Source: Owler

Orgenesis, Inc.: Orgenesis's revenue changed from $662K in Jun 2024 to $899K in Sep 2024

Orgenesis’s Trailing Twelve Months revenue changed from $662K in Jun 2024 to $899K in Sep 2024 increasing 35.8% in this time period.

Read full article »

Orgenesis, Inc.'s Competitors | Orgenesis, Inc.'s News | Orgenesis, Inc.'s Financials

Followers on Owler

Annual Revenue

$100K-5.0M

Employees

100-250

CEO

Vered Caplan

CEO Approval Rating

90/100

Orgenesis is a Maryland-based biotechnology company that researches and develops cell and gene therapies for the treatment of a wide range of diseases.